Published in Infect Immun on October 01, 2004
Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection. PLoS Negl Trop Dis (2008) 1.58
Elimination of Schistosoma mansoni Adult Worms by Rhesus Macaques: Basis for a Therapeutic Vaccine? PLoS Negl Trop Dis (2008) 1.08
Experimental vaccines in animal models for schistosomiasis. Parasitol Res (2008) 1.04
Immunology of human schistosomiasis. Parasite Immunol (2014) 0.99
DNA vaccination by electroporation and boosting with recombinant proteins enhances the efficacy of DNA vaccines for Schistosomiasis japonica. Clin Vaccine Immunol (2009) 0.89
Kicking in the Guts: Schistosoma mansoni Digestive Tract Proteins are Potential Candidates for Vaccine Development. Front Immunol (2015) 0.88
Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons. J Infect Dis (2014) 0.87
Of monkeys and men: immunomic profiling of sera from humans and non-human primates resistant to schistosomiasis reveals novel potential vaccine candidates. Front Immunol (2015) 0.85
Serological screening of the Schistosoma mansoni adult worm proteome. PLoS Negl Trop Dis (2014) 0.85
Computational vaccinology: an important strategy to discover new potential S. mansoni vaccine candidates. J Biomed Biotechnol (2011) 0.85
Imaging schistosomes in vivo. FASEB J (2009) 0.84
Vaccination with enzymatically cleaved GPI-anchored proteins from Schistosoma mansoni induces protection against challenge infection. Clin Dev Immunol (2012) 0.84
Protective Potential of Antioxidant Enzymes as Vaccines for Schistosomiasis in a Non-Human Primate Model. Front Immunol (2015) 0.83
The redox biology of schistosome parasites and applications for drug development. Curr Pharm Des (2012) 0.83
Partial immunity to Fasciola hepatica in mice after vaccination with FhSAP2 delivered as recombinant protein or DNA construct. Ethn Dis (2010) 0.82
Discovery of novel Schistosoma japonicum antigens using a targeted protein microarray approach. Parasit Vectors (2014) 0.79
Interaction Between the Neglected Tropical Disease Human Schistosomiasis and HCV Infection in Egypt: a Puzzling Relationship. J Clin Transl Hepatol (2014) 0.77
Functional expression and characterization of a cytosolic copper/zinc-superoxide dismutase of Spirometra erinacei. Parasitol Res (2010) 0.76
Specific humoral response of hosts with variable schistosomiasis susceptibility. Immunol Cell Biol (2015) 0.75
Haptoglobin Phenotypes and Susceptibility to Schistosoma Parasites Infection in Central Sudan. Mediterr J Hematol Infect Dis (2017) 0.75
The immunobiology of schistosomiasis. Nat Rev Immunol (2002) 6.07
IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J Immunol (1992) 3.98
The global epidemiological situation of schistosomiasis and new approaches to control and research. Acta Trop (2002) 3.23
An improved perfusion technique for recovering adult schistosomes from laboratory animals. Am J Trop Med Hyg (1967) 3.10
Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation. Proc Natl Acad Sci U S A (1992) 2.92
IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. J Immunol (1992) 2.78
Production of IL-10 by CD4+ T lymphocytes correlates with down-regulation of Th1 cytokine synthesis in helminth infection. J Immunol (1991) 2.70
Immunological modulation and evasion by helminth parasites in human populations. Nature (1993) 2.62
Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants. Cytometry (2001) 2.39
Exposing the immunology of naked DNA vaccines. Immunity (1995) 1.80
Four color compensation. Cytometry (1999) 1.65
Cell-mediated damage to helminths. Adv Parasitol (1984) 1.64
Immunity to helminths: Ready to tip the biochemical balance? Parasitol Today (1992) 1.60
Altered immune responses in mice with concomitant Schistosoma mansoni and Plasmodium chabaudi infections. Infect Immun (1998) 1.57
Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni. J Immunol (1999) 1.53
Immunity to schistosomes: progress toward vaccine. Science (1987) 1.49
Helminth anti-oxidant enzymes: a protective mechanism against host oxidants? Parasitol Today (1988) 1.44
Schistosomiasis vaccine:research to development. Parasitol Today (1998) 1.38
Immunity in schistosomiasis. Ann N Y Acad Sci (1969) 1.36
Type 1 and type 2 cytokine-producing mouse CD4+ and CD8+ T cells in acute Schistosoma mansoni infection. Eur J Immunol (1998) 1.32
Fluorescence spectral overlap compensation for any number of flow cytometry parameters. Ann N Y Acad Sci (1993) 1.30
Immune responses during human schistosomiasis mansoni. I. In vitro lymphocyte blastogenic responses to heterogeneous antigenic preparations from schistosome eggs, worms and cercariae. Int Arch Allergy Appl Immunol (1977) 1.28
Immunoglobulin E and effector cells in schistosomiasis. Science (1994) 1.22
Blueprint for schistosomiasis vaccine development. Acta Trop (2002) 1.21
Soluble egg antigen-stimulated T helper lymphocyte apoptosis and evidence for cell death mediated by FasL(+) T and B cells during murine Schistosoma mansoni infection. Infect Immun (2001) 1.14
Immunization with plasmid DNA encoding the integral membrane protein, Sm23, elicits a protective immune response against schistosome infection in mice. Vaccine (2001) 1.14
Post lung-stage schistosomula of Schistosoma mansoni exhibit transient susceptibility to macrophage-mediated cytotoxicity in vitro that may relate to late phase killing in vivo. Parasite Immunol (1986) 1.11
Do antioxidants play a role in schistosome host-parasite interactions? Parasitol Today (1998) 1.07
Developmental differences determine larval susceptibility to nitric oxide-mediated killing in a murine model of vaccination against Schistosoma mansoni. Infect Immun (1997) 1.06
Nucleic acid vaccines: an overview. Vaccine (1997) 1.05
Schistosoma mansoni: the developmental regulation and immunolocalization of antioxidant enzymes. Exp Parasitol (1997) 1.04
Fas ligand-expressing B-1a lymphocytes mediate CD4(+)-T-cell apoptosis during schistosomal infection: induction by interleukin 4 (IL-4) and IL-10. Infect Immun (2002) 1.04
Comparison of Schistosoma mansoni migration patterns in normal and irradiated cercaria-immunized mice by means of autoradiographic analysis. Evidence that worm elimination occurs after the skin phase in immunized mice. Am J Trop Med Hyg (1984) 1.04
Type 1 CD8+ T cell responses during infection with the helminth Schistosoma mansoni. J Immunol (1996) 1.02
Mechanisms of immune evasion in schistosomiasis. Contrib Microbiol Immunol (1987) 1.02
Practical and ethical issues in the development of a vaccine against schistosomiasis mansoni. Am J Trop Med Hyg (2002) 1.01
Antioxidant systems in Schistosoma mansoni: correlation between susceptibility to oxidant killing and the levels of scavengers of hydrogen peroxide and oxygen free radicals. Int J Parasitol (1988) 1.01
Defining a schistosomiasis vaccination strategy - is it really Th1 versus Th2? Parasitol Today (2000) 1.00
Human immunity to Schistosoma mansoni: observations on mechanisms, and implications for control. Immunol Invest (1992) 0.97
Schistosomiasis vaccine development: progress and prospects. Mem Inst Oswaldo Cruz (1998) 0.97
Schistosoma mansoni: levels of antioxidants and resistance to oxidants increase during development. Exp Parasitol (1990) 0.94
Microplate enzyme-linked immunosorbent assay in the study of the structural relationship between myosin light chains. J Immunol Methods (1979) 0.93
Identification and purification of a second form of Cu/Zn superoxide dismutase from Schistosoma mansoni. Infect Immun (1992) 0.92
Intradermal immunization of rats with plasmid DNA encoding Schistosoma mansoni 28 kDa glutathione S-transferase. Parasite Immunol (1997) 0.88
Cross-reactivity of Schistosoma mansoni cytosolic superoxide dismutase, a protective vaccine candidate, with host superoxide dismutase and identification of parasite-specific B epitopes. Infect Immun (2004) 0.85
Expression and characterization of glutathione peroxidase activity in the human blood fluke Schistosoma mansoni. Infect Immun (1996) 0.85
Immune attrition of adult schistosomes. Parasite Immunol (1993) 0.83
DNA vaccination with asparaginyl endopeptidase (Sm32) from the parasite Schistosoma mansoni: anti-fecundity effect induced in mice. Vaccine (2001) 0.82
Schistosoma mansoni: cloning the gene encoding glutathione peroxidase. Exp Parasitol (1995) 0.80
Transfer of Schistosoma mansoni into the mesenteric veins of hamsters. Int J Parasitol (1976) 0.79
Intra-pinna anti-tumor vaccination with self-replicating infectious RNA or with DNA encoding a model tumor antigen and a cytokine. Gene Ther (2000) 0.78
Multiparameter data acquisition and analysis of leukocytes by flow cytometry. Methods Cell Biol (2001) 0.76
The genome of the blood fluke Schistosoma mansoni. Nature (2009) 5.94
A systematically improved high quality genome and transcriptome of the human blood fluke Schistosoma mansoni. PLoS Negl Trop Dis (2012) 2.32
New policies for using anthelmintics in high risk groups. Trends Parasitol (2002) 1.63
Understanding avoidance, refusal, and abandonment of chemotherapy before and after cystectomy for bladder cancer. Urology (2013) 1.52
Cognitive skills assessment during robot-assisted surgery: separating the wheat from the chaff. BJU Int (2015) 1.50
Delay to formalin fixation effect on breast biomarkers. Mod Pathol (2009) 1.46
Does body mass index impact the performance of robot-assisted intracorporeal ileal conduit? J Endourol (2012) 1.45
Genomic linkage map of the human blood fluke Schistosoma mansoni. Genome Biol (2009) 1.30
Schistosoma mansoni TGF-beta receptor II: role in host ligand-induced regulation of a schistosome target gene. PLoS Pathog (2006) 1.29
Current status of robot-assisted surgery in urology: a multi-national survey of 297 urologic surgeons. Can J Urol (2009) 1.28
Inhibition of the complement membrane attack complex by Schistosoma mansoni paramyosin. Infect Immun (2003) 1.25
RhoA as a mediator of clinically relevant androgen action in prostate cancer cells. Mol Endocrinol (2012) 1.16
Socioeconomic determinants of schistosomiasis in a poor rural area in Brazil. Acta Trop (2006) 1.15
Evolution of a novel subfamily of nuclear receptors with members that each contain two DNA binding domains. BMC Evol Biol (2007) 1.08
Genetic and molecular basis of drug resistance and species-specific drug action in schistosome parasites. Science (2013) 1.07
Cetuximab-induced hypomagnesemia in patients with colorectal cancer. Clin Colorectal Cancer (2006) 1.05
Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with Barrett's esophagus. Lasers Surg Med (2011) 1.04
Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, 1985-2010. Oral Oncol (2011) 1.01
Accuracy and biological variation of human serum paraoxonase 1 activity and polymorphism (Q192R) by kinetic enzyme assay. Clin Chem (2006) 1.01
Mapping of the complement C9 binding domain in paramyosin of the blood fluke Schistosoma mansoni. Int J Parasitol (2006) 0.98
Efficient genotyping of Schistosoma mansoni miracidia following whole genome amplification. Mol Biochem Parasitol (2009) 0.98
Assessment of risk factors for 30-day hospital readmission after surgical cytoreduction in epithelial ovarian carcinoma. Int J Gynecol Cancer (2011) 0.97
Exposure to Schistosoma mansoni infection in a rural area in Brazil. Part III: household aggregation of water-contact behaviour. Trop Med Int Health (2004) 0.97
Advances in schistosome genomics. Trends Parasitol (2004) 0.97
Epstein-Barr virus coinfection in children boosts cytomegalovirus-induced differentiation of natural killer cells. J Virol (2013) 0.95
Expression of functional Schistosoma mansoni Smad4: role in Erk-mediated transforming growth factor beta (TGF-beta) down-regulation. J Biol Chem (2003) 0.94
Treatment of locally advanced unresectable pancreatic cancer: a 10-year experience. J Gastrointest Oncol (2012) 0.94
Thyroid hormone receptor orthologues from invertebrate species with emphasis on Schistosoma mansoni. BMC Evol Biol (2007) 0.93
Human schistosomiasis mansoni: intensity of infection differentially affects the production of interleukin-10, interferon-gamma and interleukin-13 by soluble egg antigen or adult worm antigen stimulated cultures. Trans R Soc Trop Med Hyg (2004) 0.93
Photodynamic therapy with 3-(1'-hexyloxyethyl) pyropheophorbide a for cancer of the oral cavity. Clin Cancer Res (2013) 0.92
Production of calcium-mobilizing metabolites by a novel member of the ADP-ribosyl cyclase family expressed in Schistosoma mansoni. Biochemistry (2005) 0.92
Short-term quality-of-life assessed after robot-assisted radical cystectomy: a prospective analysis. BJU Int (2008) 0.92
Cytological and biochemical evidence for a gonad-preferential interplay of SmFKBP12 and SmTbetaR-I in Schistosoma mansoni. Mol Biochem Parasitol (2004) 0.91
Identification and characterization of a nuclear receptor subfamily I member in the Platyhelminth Schistosoma mansoni (SmNR1). FEBS J (2006) 0.91
Effect of delayed formalin fixation on estrogen and progesterone receptors in breast cancer: a study of three different clones. Am J Clin Pathol (2010) 0.91
Schistosoma mansoni: SmE78, a nuclear receptor orthologue of Drosophila ecdysone-induced protein 78. Exp Parasitol (2008) 0.90
Development and validation of a composite scoring system for robot-assisted surgical training--the Robotic Skills Assessment Score. J Surg Res (2013) 0.90
Characteristics of the lax vowel space in dysarthria. J Speech Lang Hear Res (2005) 0.89
Chest tube-delivered bupivacaine improves pain and decreases opioid use after thoracoscopy. Ann Thorac Surg (2009) 0.89
Schistosoma mansoni (Platyhelminthes, Trematoda) nuclear receptors: sixteen new members and a novel subfamily. Gene (2006) 0.88
Identification and characterization of a novel fushi tarazu factor 1 (FTZ-F1) nuclear receptor in Schistosoma mansoni. Mol Biochem Parasitol (2006) 0.86
Adjuvant intraoperative photodynamic therapy in head and neck cancer. JAMA Otolaryngol Head Neck Surg (2013) 0.86
Identification and characterization of an R-Smad ortholog (SmSmad1B) from Schistosoma mansoni. FEBS J (2007) 0.86
A phase II study of first-line biweekly capecitabine and bevacizumab in elderly patients with metastatic colorectal cancer. Crit Rev Oncol Hematol (2008) 0.86
Comparative analysis of global practice patterns in urologic robot-assisted surgery. J Endourol (2010) 0.85
Augmented-reality-based skills training for robot-assisted urethrovesical anastomosis: a multi-institutional randomised controlled trial. BJU Int (2014) 0.85
Cross-reactivity of Schistosoma mansoni cytosolic superoxide dismutase, a protective vaccine candidate, with host superoxide dismutase and identification of parasite-specific B epitopes. Infect Immun (2004) 0.85
Molecular cloning and characterization of WD40-repeat protein from Clonorchis sinensis. Parasitol Res (2007) 0.84
Effect of human TGF-β on the gene expression profile of Schistosoma mansoni adult worms. Mol Biochem Parasitol (2012) 0.84
Pilot study of gefitinib, oxaliplatin, and radiotherapy for esophageal adenocarcinoma: tissue effect predicts clinical response. Am J Clin Oncol (2008) 0.84
Apical margins after robot-assisted radical prostatectomy: does technique matter? J Endourol (2009) 0.84
Characterisation of a Rho homologue of Schistosoma mansoni. Int J Parasitol (2003) 0.83
SmTR2/4, a Schistosoma mansoni homologue of TR2/TR4 orphan nuclear receptor. Int J Parasitol (2006) 0.83
Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer. J Gastrointest Oncol (2013) 0.83
Efficient linkage mapping using exome capture and extreme QTL in schistosome parasites. BMC Genomics (2014) 0.83
Tumour eosinophilia combined with an immunohistochemistry panel is useful in the differentiation of type B3 thymoma from thymic carcinoma. Int J Exp Pathol (2010) 0.82
The Schistosoma mansoni gene index: gene discovery and biology by reconstruction and analysis of expressed gene sequences. J Parasitol (2003) 0.82
Evolution of sex chromosomes ZW of Schistosoma mansoni inferred from chromosome paint and BAC mapping analyses. Parasitol Int (2012) 0.81
Qualitative radiology assessment of tumor response: does it measure up? Clin Imaging (2008) 0.81
Vaccination with antioxidant enzymes confers protective immunity against challenge infection with Schistosoma mansoni. Mem Inst Oswaldo Cruz (2004) 0.81
The spatial distribution of Schistosoma mansoni infection before and after chemotherapy in the Jequitinhonha Valley in Brazil. Mem Inst Oswaldo Cruz (2006) 0.80
Outcomes of endoscopic resection for high-grade dysplasia and esophageal cancer. Surg Endosc (2014) 0.80
Thick primary melanoma has a heterogeneous tumor biology: an institutional series. World J Surg Oncol (2011) 0.80
Sex differences in cyclosporine pharmacokinetics and ABCB1 gene expression in mononuclear blood cells in African American and Caucasian renal transplant recipients. J Clin Pharmacol (2013) 0.79
Nuclear hormone receptors in parasitic helminths. Mol Cell Endocrinol (2010) 0.79
Efficacy of robot-assisted radical cystectomy (RARC) in advanced bladder cancer: results from the International Radical Cystectomy Consortium (IRCC). BJU Int (2014) 0.79
Impact of body mass index on robot-assisted radical cystectomy. JSLS (2008) 0.79
Current trends in robot assisted surgery: a survey of gynecologic oncologists. Int J Med Robot (2010) 0.79
A steroid-independent regimen of bortezomib, liposomal doxorubicin and thalidomide demonstrate high response rates in newly diagnosed multiple myeloma patients. Br J Haematol (2011) 0.79
Intensive radiographic and biomarker surveillance in stage II and III colorectal cancer. Oncology (2012) 0.78
Cloning of Schistosoma mansoni Seven in Absentia (SmSINA)(+) homologue cDNA, a gene involved in ubiquitination of SmRXR1 and SmRXR2. Mol Biochem Parasitol (2003) 0.78
Schistosoma mansoni: Heterologous complementation of a yeast null mutant by SmRbx, a protein similar to a RING box protein involved in ubiquitination. Exp Parasitol (2007) 0.78
Validation of Robotic Surgery Simulator (RoSS). Stud Health Technol Inform (2011) 0.78
Stop and go FOLFOX plus bevacizumab chemotherapy in the first-line treatment of metastatic colorectal cancer. Oncology (2010) 0.77
Determination of genotypes using a fully automated molecular detection system. Arch Pathol Lab Med (2015) 0.77
Characterization of the DNA-binding properties and the transactivation activity of Schistosoma mansoni nuclear receptor fushi tarazu-factor 1alpha (SmFTZ-F1alpha). Mol Biochem Parasitol (2006) 0.76
Comparison of Intelligibility Measures for Adults With Parkinson's Disease, Adults With Multiple Sclerosis, and Healthy Controls. J Speech Lang Hear Res (2016) 0.75
DNA binding and transactivation properties of the Schistosoma mansoni constitutive androstane receptor homologue. Mol Biochem Parasitol (2006) 0.75
CD138 (Syndecan-1) in thymic tumors: correlation with various World Health Organization types and clinical outcome. Int J Clin Exp Pathol (2010) 0.75
A prospective study of pain control by a 2-step irradiance schedule during topical photodynamic therapy of nonmelanoma skin cancer. Dermatol Surg (2014) 0.75
Editorial. Mol Biochem Parasitol (2017) 0.75